[REGN] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 0.15%
YoY- 46.64%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 1,608,022 1,511,485 1,582,447 1,500,673 1,470,116 1,318,991 1,226,827 19.82%
PBT 656,074 585,398 554,767 565,605 525,850 432,289 341,527 54.71%
Tax 104,662 107,418 381,248 177,288 138,106 183,358 88,412 11.94%
NP 551,412 477,980 173,519 388,317 387,744 248,931 253,115 68.28%
Tax Rate -15.95% -18.35% -68.72% -31.34% -26.26% -42.42% -25.89% -
Total Cost 1,056,610 1,033,505 1,408,928 1,112,356 1,082,372 1,070,060 973,712 5.61%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 34.29 31.62 10.97 25.88 26.38 18.87 20.63 40.44%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS 5.12 4.44 1.62 3.64 3.66 2.36 2.41 65.48%
EPS Diluted 4.82 4.16 1.49 3.32 3.34 2.16 2.19 69.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.